Nicholas DeVito/scholars.duke.edu
Jan 27, 2025, 18:09
Nicholas DeVito: Stellar results from Bot/Bal in MSS colorectal cancer
Nicholas DeVito, Assistant Professor of Medicine at Duke University, Division of Medical Oncology, shared a post on LinkedIn:
“Stellar results from Bot/Bal in MSS colorectal cancer – an immunotherapy combo I have been excited about since data presented at SITC 2022 which inspired our first-line trial with these agents.
It is a thrilling time to be a GI oncologist where the age of immunotherapy in these cancers has arrived.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 27, 2025, 18:09
Jan 27, 2025, 17:49
Jan 27, 2025, 17:30
Jan 27, 2025, 17:28
Jan 27, 2025, 17:25
Jan 27, 2025, 17:23
Jan 27, 2025, 17:17
Jan 27, 2025, 17:12